Cidara Therapeutics (CDTX) had the highest return between January 1, 2015 and August 31, 2015 by a mid-cap US stock, returning 1,678.8%.
| ASSET | DATE | % RETURN |
|---|---|---|
Cidara Therapeutics (CDTX) | 1/1/2015 - 8/31/2015 | 1,678.75% |
Galapagos NV ADR (GLPG) | 1/1/2015 - 8/31/2015 | 219.58% |
Ultragenyx (RARE) | 1/1/2015 - 8/31/2015 | 151.28% |
Sarepta Therapeutics (SRPT) | 1/1/2015 - 8/31/2015 | 144.86% |
Travere Therapeutics (TVTX) | 1/1/2015 - 8/31/2015 | 122.38% |
Caesars Entertainment (CZR) | 1/1/2015 - 8/31/2015 | 122.17% |
Supernus Pharmaceuticals (SUPN) | 1/1/2015 - 8/31/2015 | 116.85% |
Dycom Industries (DY) | 1/1/2015 - 8/31/2015 | 101.27% |
Wayfair (W) | 1/1/2015 - 8/31/2015 | 86.59% |
Ambarella (AMBA) | 1/1/2015 - 8/31/2015 | 83.9% |
Halozyme Therapeutics (HALO) | 1/1/2015 - 8/31/2015 | 78.71% |
Uniqure (QURE) | 1/1/2015 - 8/31/2015 | 78.6% |
Globant (GLOB) | 1/1/2015 - 8/31/2015 | 76.05% |
Repligen (RGEN) | 1/1/2015 - 8/31/2015 | 71.86% |
Ligand Pharmaceuticals (LGND) | 1/1/2015 - 8/31/2015 | 71.31% |
Amicus Therapeutics (FOLD) | 1/1/2015 - 8/31/2015 | 70.78% |
Corcept Therapeutics (CORT) | 1/1/2015 - 8/31/2015 | 66.11% |
Soleno Therapeutics (SLNO) | 1/1/2015 - 8/31/2015 | 60.42% |
Sapiens International (SPNS) | 1/1/2015 - 8/31/2015 | 60.28% |
Bausch Health Companies (BHC) | 1/1/2015 - 8/31/2015 | 60.17% |
Pampa Energia SA ADR (PAM) | 1/1/2015 - 8/31/2015 | 58.29% |
NexGen Energy (NXE) | 1/1/2015 - 8/31/2015 | 55.63% |
Primo Brands (PRMB) | 1/1/2015 - 8/31/2015 | 55.43% |
Post (POST) | 1/1/2015 - 8/31/2015 | 55.17% |
Formula Systems 1985 Ltd ADR (FORTY) | 1/1/2015 - 8/31/2015 | 54.04% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
